271 related articles for article (PubMed ID: 7511661)
1. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
[TBL] [Abstract][Full Text] [Related]
2. Class I MHC-peptide interactions: structural requirements and functional implications.
Grey HM; Ruppert J; Vitiello A; Sidney J; Kast WM; Kubo RT; Sette A
Cancer Surv; 1995; 22():37-49. PubMed ID: 7536628
[TBL] [Abstract][Full Text] [Related]
3. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM
J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538
[TBL] [Abstract][Full Text] [Related]
4. Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
[TBL] [Abstract][Full Text] [Related]
5. Definition of specific peptide motifs for four major HLA-A alleles.
Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7.
Rudolf MP; Man S; Melief CJ; Sette A; Kast WM
Clin Cancer Res; 2001 Mar; 7(3 Suppl):788s-795s. PubMed ID: 11300474
[TBL] [Abstract][Full Text] [Related]
7. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
8. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.
Bartholomew JS; Stacey SN; Coles B; Burt DJ; Arrand JR; Stern PL
Eur J Immunol; 1994 Dec; 24(12):3175-9. PubMed ID: 7805746
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.
Castellanos MR; Hayes RL; Maiman MA
Gynecol Oncol; 2001 Jul; 82(1):77-83. PubMed ID: 11426965
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.
Feltkamp MC; Smits HL; Vierboom MP; Minnaar RP; de Jongh BM; Drijfhout JW; ter Schegget J; Melief CJ; Kast WM
Eur J Immunol; 1993 Sep; 23(9):2242-9. PubMed ID: 7690326
[TBL] [Abstract][Full Text] [Related]
11. A pattern search method for putative anchor residues in T cell epitopes.
Hobohm U; Meyerhans A
Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope.
Gao L; Walter J; Travers P; Stauss H; Chain BM
J Immunol; 1995 Dec; 155(12):5519-26. PubMed ID: 7499833
[TBL] [Abstract][Full Text] [Related]
13. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes.
Doan T; Chambers M; Street M; Fernando GJ; Herd K; Lambert P; Tindle R
Virology; 1998 May; 244(2):352-64. PubMed ID: 9601506
[TBL] [Abstract][Full Text] [Related]
14. Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.
Lipford GB; Bauer S; Wagner H; Heeg K
Immunology; 1995 Feb; 84(2):298-303. PubMed ID: 7751006
[TBL] [Abstract][Full Text] [Related]
15. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.
Kondo A; Sidney J; Southwood S; del Guercio MF; Appella E; Sakamoto H; Celis E; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1995 Nov; 155(9):4307-12. PubMed ID: 7594589
[TBL] [Abstract][Full Text] [Related]
16. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
Sette A; Sidney J; Oseroff C; del Guercio MF; Southwood S; Arrhenius T; Powell MF; Colón SM; Gaeta FC; Grey HM
J Immunol; 1993 Sep; 151(6):3163-70. PubMed ID: 7690794
[TBL] [Abstract][Full Text] [Related]
17. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
Collins EJ; Booth BL; Cerundolo V
J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
[TBL] [Abstract][Full Text] [Related]
18. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino M; Parker KC; Shiloach J; Turner RV; Tsuchida T; Garfield M; Biddison WE; Coligan JE
J Immunol; 1994 Jan; 152(2):620-31. PubMed ID: 7506728
[TBL] [Abstract][Full Text] [Related]
19. Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
Hara M; Matsueda S; Tamura M; Takedatsu H; Tanaka M; Kawano K; Mochizuki K; Kamura T; Itoh K; Harada M
Int J Oncol; 2005 Nov; 27(5):1371-9. PubMed ID: 16211234
[TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.
Tarpey I; Stacey S; Hickling J; Birley HD; Renton A; McIndoe A; Davies DH
Immunology; 1994 Feb; 81(2):222-7. PubMed ID: 8157270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]